Skip to main content

Table 3 Statistically significant differences in dynamic SUVmax changes in squamous cell carcinoma and malignant melanoma

From: Dynamic changes in 18F-borono-L-phenylalanine uptake in unresectable, advanced, or recurrent squamous cell carcinoma of the head and neck and malignant melanoma during boron neutron capture therapy patient selection

  

Squamous cell carcinoma

Malignant melanoma

From 30 min to 60 min

P value

 

0.1064

0.6504

Difference in SUVmaxa

Mean ± SD (Range)

1.02 ± 0.61 (0.2–2.7)

1.1 ± 1.7 (−1.4–2)

RI

Mean ± SD (Range)

17.6 ± 7.3 (4.7–28.0)

12.0 ± 15.5 (−17.1–29.9)

 

Number of patients with increase

0

3

 

Number of patients with decrease

20

5

From 60 min to 120 min

P value

 

0.1263

0.7098

Difference in SUVmax

Mean ± SD (Range)

0.96 ± 0.56 (0.3–2.6)

0.91 ± 0.74 (−0.2–2.3)

RI

Mean ± SD (Range)

20 ± 6.6 (5.2–29.2)

13.6 ± 10.9 (−0.02–32.4)

 

Number of patients with increase

0

1

 

Number of patients with decrease

20

7

From 30 min to 120 min

P value

 

0.0023

0.412

Difference in SUVmax

Mean ± SD (Range)

1.98 ± 1.02 (0.6–4.7)

2.03 ± 2.38 (−1.1–7)

RI

Mean ± SD (Range)

34.0 ± 8.7 (8.7–46.7)

22.4 ± 22.3 (−13.4–52.1)

 

Number of patients with increase

0

2

 

Number of patients with decrease

20

6

  1. aDifference in SUVmax difference was calculated as delayed SUVmax minus earlier SUVmax
  2. Abbreviations: RI Retention index, SD Standard deviation, SUVmax Maximum standardized uptake value